Research in Social and Administrative Pharmacy
Volume 6, Issue 4 , Pages 324-333 , December 2010

Examining the development of pharmacist-physician collaboration over 3 months

  • Yifei Liu, B.S.Pharm., Ph.D.

      Affiliations

    • Division of Pharmacy Practice and Administration, School of Pharmacy, The University of Missouri, 4248 Health Sciences Building, Kansas City, MO 64108, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 816 235 6820; fax: +1 816 235 6008.
    • ,
  • William R. Doucette, Ph.D.

      Affiliations

    • Division of Health Services Research, College of Pharmacy, The University of Iowa, Iowa City, IA 52242, USA
    • ,
  • Karen B. Farris, Ph.D.

      Affiliations

    • Division of Health Services Research, College of Pharmacy, The University of Iowa, Iowa City, IA 52242, USA

References 

  1. Thomas JD. Organizations in Action. New York, NY: McGraw-Hill; 1976;
  2. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428–437
  3. Munroe WP, Kunz K, Dalmady-Israel C, Potter L, Schonfeld WH. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther. 1997;19:113–123
  4. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–270
  5. Berringer R, Shibley MC, Cary CC, Pugh CB, Powers PA, Rafi JA. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999;39:791–797
  6. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999;159:1939–1945
  7. McMullin ST, Hennenfent JA, Ritchie D, et al. A prospective randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999;159:2306–2309
  8. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc. 2000;40:157–165
  9. Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HG. A retrospective cohort analysis of the clinical effectiveness of a physician–pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy. 2002;22:1294–1300
  10. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173–184
  11. McDonough RP, Doucette WR. Drug therapy management: an empirical report of drug therapy problems, pharmacists' interventions, and results of pharmacists' actions. J Am Pharm Assoc. 2003;43:511–518
  12. Chrischilles EA, Carter BL, Lund BC, et al. Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc. 2004;44:337–349
  13. Williams ME, Pulliam CC, Hunter R, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004;52:93–98
  14. Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther. 2005;27:1104–1111
  15. Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828–1832
  16. Kallail JK, Stanton SR. Pharmacy-physician communications: potential to reduce medication errors. J Am Pharm Assoc. 2006;46:618–620
  17. Christensen DB, Roth M, Trygstad T, Byrd J. Evaluation of a pilot medication therapy management project within the North Carolina state health plan. J Am Pharm Assoc. 2007;47:471–483
  18. Ferro LA, Marcrom RE, Garrelts L, et al. Collaborative practice agreements between pharmacists and physicians. J Am Pharm Assoc. 1998;38:655–664
  19. McDonough RP, Doucette WR. Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc. 2001;41:682–692
  20. Zillich AJ, McDonough RP, Carter BL, Doucette WR. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother. 2004;38:764–770
  21. Zillich AJ, Doucette WR, Carter BL, Kreiter CD. Development and initial validation of an instrument to measure physician-pharmacist collaboration from the physician perspective. Value Health. 2005;8:59–66
  22. Doucette WR, Nevins J, McDonough RD. Factors affecting collaborative care between pharmacists and physicians. Res Social Adm Pharm. 2005;1:565–578
  23. Zillich AJ, Milchak JL, Carter BL, Doucette WR. Utility of a questionnaire to measure physician-pharmacist collaborative relationships. J Am Pharm Assoc. 2006;46:453–458
  24. Levy PS, Lemeshow S. How large a sample do we need? Chapter 3. Simple random sampling. In:  Levy PS,  Lemeshow S editor. Sampling of Population: Methods and Applications. 3rd ed.. New York, NY: John Wiley & Sons; 1999;p. 70–75
  25. Herbert KE, Urmie JM, Newland BA, Farris KB. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior. Res Social Adm Pharm. 2006;2:299–314
  26. Dillman DA. Mail and Internet Surveys: The Tailored Design Method. 2nd ed.. New York, NY: John Wiley Company; 1999;
  27. In:  Kleinbaum DG,  Kupper LL,  Muller KE,  Nizam A editor. Chapter 12, Regression diagnostics. Applied Regression Analysis and Other Multivariable Methods. 3rd ed.. Belmont, CA: Duxbury Press; 1998;p. 237–249
  28. Ajzen I. Attitudes, Personality, and Behavior. Chicago, IL: Dorsey Press; 1988;
  29. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179–211
  30. Dieleman SL, Farris KB, Feeny D, Johnson JA, Tsuyuki RT, Brilliant S. Primary health care teams: team members' perceptions of the collaborative process. J Interprof Care. 2004;18:75–78
  31. Farris KB. Relationships and responsibilities are critical to team care in medication management. Res Social Adm Pharm. 2005;1:369–374
  32. Sutton S. Predicting and explaining intentions and behavior: how well are we doing?. J Appl Soc Psychol. 1998;28:1317–1338
  33. Bajcar JM, Kennie N, Einarson TR. Collaborative medication management in a team-based primary care practice: an explanatory conceptual framework. Res Social Adm Pharm. 2005;1:408–429
  34. Dolovich L, Pottie K, Kaczorowski J, et al. Integrating family medicine and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther. 2008;83:913–917

PII: S1551-7411(09)00136-3

doi: 10.1016/j.sapharm.2009.11.002

Research in Social and Administrative Pharmacy
Volume 6, Issue 4 , Pages 324-333 , December 2010

Article Tools

* Image Usage & Resolution